Plasma N-terminal Proatrial Natriuretic Peptide Concentration in Cats with Hypertrophic Cardiomyopathy
dc.contributor.author | MacLean, Heidi Norma | en |
dc.contributor.committeechair | Abbott, Jonathan A. | en |
dc.contributor.committeemember | Pyle, Robert Lee | en |
dc.contributor.committeemember | Huckle, William R. | en |
dc.contributor.department | Veterinary Medical Sciences | en |
dc.date.accessioned | 2014-03-14T20:32:50Z | en |
dc.date.adate | 2004-03-26 | en |
dc.date.available | 2014-03-14T20:32:50Z | en |
dc.date.issued | 2004-03-12 | en |
dc.date.rdate | 2012-10-01 | en |
dc.date.sdate | 2004-03-24 | en |
dc.description.abstract | Objective: We sought to determine N-terminal proatrial natriuretic peptide concentrations [Nt-proANP] in plasma from cats with hypertrophic cardiomyopathy (HCM). Secondarily, we wished to evaluate the relationship between [Nt-proANP] and echocardiographic variables. Methods: Venous blood samples were obtained from seventeen cats with HCM and from nineteen healthy cats. Plasma [Nt-proANP] was determined using an ELISA assay. The relationship between plasma [Nt-proANP] and M-mode, 2-dimensional and Doppler echocardiographic variables was evaluated. Cats that were hyperthyroid or had evidence of renal disease were excluded from the study. Results: The mean plasma [Nt-proANP] was higher in cats with HCM (3.81 +/- 1.23 pmol/l) than in control cats (3.08 +/- 1.41 pmol/l); however, this difference was not statistically significant (p=0.17). There was a significant correlation between plasma [Nt-proANP] and left ventricular posterior wall thickness (r = 0.42; p=0.01). Additionally, plasma [Nt-proANP] was correlated with left atrial size (r = 0.35; p=0.03). A linear regression model was developed to further explore these relationships. LAs2D and LVPWd had an interactive effect on plasma [Nt-proANP] (R2 = 0.2737; p= 0.02). There was no correlation between any other echocardiographic variable and plasma [Nt-proANP]. There was no correlation between plasma [Nt-proANP] and heart rate (HR), body-weight, or age. Conclusions: Cats with HCM do not have significantly higher plasma [Nt-proANP] than normal cats. There was a significant linear relationship between [Nt-proANP] and LAs2D, LVPWd and the model that described their interaction. | en |
dc.description.degree | Master of Science | en |
dc.identifier.other | etd-03242004-165009 | en |
dc.identifier.sourceurl | http://scholar.lib.vt.edu/theses/available/etd-03242004-165009/ | en |
dc.identifier.uri | http://hdl.handle.net/10919/31538 | en |
dc.publisher | Virginia Tech | en |
dc.relation.haspart | ANP_macLean_thesis_final[1].pdf | en |
dc.rights | In Copyright | en |
dc.rights.uri | http://rightsstatements.org/vocab/InC/1.0/ | en |
dc.subject | hypertrophic cardiomyopathy | en |
dc.subject | diastolic dysfunction | en |
dc.subject | feline | en |
dc.subject | atrial natriuretic peptide | en |
dc.title | Plasma N-terminal Proatrial Natriuretic Peptide Concentration in Cats with Hypertrophic Cardiomyopathy | en |
dc.type | Thesis | en |
thesis.degree.discipline | Veterinary Medical Sciences | en |
thesis.degree.grantor | Virginia Polytechnic Institute and State University | en |
thesis.degree.level | masters | en |
thesis.degree.name | Master of Science | en |
Files
Original bundle
1 - 1 of 1
Loading...
- Name:
- ANP_macLean_thesis_final[1].pdf
- Size:
- 389.08 KB
- Format:
- Adobe Portable Document Format